» Articles » PMID: 31284119

Kratom As a Substitute for Opioids: Results from an Online Survey

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2019 Jul 9
PMID 31284119
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Kratom is a South Eastern Asian tree whose leaves are used to make tea-like brews or swallowed in powdered form for various health and well-being reasons including to relieve pain and opioid withdrawal. It is important to learn more about the potential public health impact of kratom in the context of the opioid epidemic.

Methods: An anonymous online survey of kratom users (2867 current users and 157 former users) was conducted in September 2017 through the American Kratom Association and associated social media sites.

Results: Kratom was used primarily to relieve pain (endorsed by 48% of respondents), for anxiety, PTSD, or depression (22%), to increase energy or focus (10%) and to help cut down on opioid use and/or relieve withdrawal (10%). Over 90% of respondents who used it in place of opioids indicated that it was helpful to relieve pain, reduce opioid use, and relieve withdrawal. The reported incidence of bad adverse reactions was 13%, and reactions were overwhelmingly mild and self-managed.

Conclusions: Respondents reported using kratom for conditions which often require use of opioids, including pain and reduction of opioid use. The high self-reported efficacy and low incidence of adverse reactions associated with kratom use suggest that it may provide a potential alternative to opioids for some persons even though it has not been evaluated in multi-center clinical trials or approved for any therapeutic purpose. Further study of kratom, including systematic characterization of its safety and efficacy for various conditions is warranted.

Citing Articles

An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans.

Prevete E, Theunissen E, Kuypers K, Paci R, Reckweg J, Cavarra M Psychopharmacology (Berl). 2024; .

PMID: 39724441 DOI: 10.1007/s00213-024-06734-2.


Kratom: A Narrative Review of the Possible Clinical Uses and Dangers of This Opioid-Like Plant.

Edinoff A, Kaufman S, Mahoney T, Upshaw W, Gong J, Cornett E Cureus. 2024; 16(11):e73058.

PMID: 39640144 PMC: 11619718. DOI: 10.7759/cureus.73058.


Kratom (Mitragyna speciosa) use for self-management of pain: Insights from cross-sectional and ecological momentary assessment data.

Mun C, Panlilio L, Dunn K, Thrul J, McCurdy C, Epstein D J Pain. 2024; 26:104726.

PMID: 39505119 PMC: 11781972. DOI: 10.1016/j.jpain.2024.104726.


Time course of kratom effects via ecological momentary assessment, by product type, dose amount, and assayed alkaloid content.

Smith K, Panlilio L, Sharma A, McCurdy C, Feldman J, Mukhopadhyay S Drug Alcohol Depend. 2024; 264:112460.

PMID: 39405600 PMC: 11527584. DOI: 10.1016/j.drugalcdep.2024.112460.


Associations Between Opioid and Kratom Use in the USA: Differences by Race/Ethnicity and Sexual Orientation.

LoParco C, Bone C, Berg C, Rossheim M, Peeri N, Tillett K J Racial Ethn Health Disparities. 2024; .

PMID: 39196491 DOI: 10.1007/s40615-024-02142-6.